Clinical Trials Browser

Withdrawn × Everolimus × Genitourinary × Clear all

NCT01616186 2013-04-08

Everolimus/Sorafenib or Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC)

Phase 2 Withdrawn

Carcinoma, Renal Cell